Cozad Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Hold |
1,340
| – | – | 0.02% | 392 |
|
|
2025
Q1 | $228K | Sell |
1,340
-545
| -29% | -$92.7K | 0.02% | 368 |
|
|
2024
Q4 | $313K | Sell |
1,885
-275
| -13% | -$45.7K | 0.03% | 318 |
|
|
2024
Q3 | $371K | Hold |
2,160
| – | – | 0.04% | 293 |
|
|
2024
Q2 | $333K | Hold |
2,160
| – | – | 0.03% | 306 |
|
|
2024
Q1 | $332K | Hold |
2,160
| – | – | 0.03% | 304 |
|
|
2023
Q4 | $341K | Sell |
2,160
-100
| -4% | -$15.8K | 0.04% | 299 |
|
|
2023
Q3 | $331K | Sell |
2,260
-135
| -6% | -$19.8K | 0.04% | 286 |
|
|
2023
Q2 | $367K | Hold |
2,395
| – | – | 0.05% | 279 |
|
|
2023
Q1 | $371K | Hold |
2,395
| – | – | 0.05% | 266 |
|
|
2022
Q4 | $369K | Hold |
2,395
| – | – | 0.05% | 269 |
|
|
2022
Q3 | $316K | Hold |
2,395
| – | – | 0.05% | 265 |
|
|
2022
Q2 | $325K | Hold |
2,395
| – | – | 0.05% | 271 |
|
|
2022
Q1 | $357K | Sell |
2,395
-2,995
| -56% | -$446K | 0.05% | 271 |
|
|
2021
Q4 | $872K | Hold |
5,390
| – | – | 0.12% | 168 |
|
|
2021
Q3 | $896K | Buy |
5,390
+2,695
| +100% | +$448K | 0.14% | 159 |
|
|
2021
Q2 | $465K | Hold |
2,695
| – | – | 0.07% | 220 |
|
|
2021
Q1 | $433K | Sell |
2,695
-450
| -14% | -$72.3K | 0.07% | 229 |
|
|
2020
Q4 | $528K | Sell |
3,145
-250
| -7% | -$42K | 0.09% | 198 |
|
|
2020
Q3 | $534K | Sell |
3,395
-425
| -11% | -$66.8K | 0.1% | 192 |
|
|
2020
Q2 | $641K | Buy |
3,820
+1,345
| +54% | +$226K | 0.13% | 172 |
|
|
2020
Q1 | $325K | Hold |
2,475
| – | – | 0.11% | 156 |
|
|
2019
Q4 | $368K | Sell |
2,475
-1,256
| -34% | -$187K | 0.1% | 176 |
|
|
2019
Q3 | $462K | Sell |
3,731
-1,775
| -32% | -$220K | 0.13% | 152 |
|
|
2019
Q2 | $775K | Hold |
5,506
| – | – | 0.22% | 114 |
|
|
2019
Q1 | $831K | Sell |
5,506
-660
| -11% | -$99.6K | 0.25% | 112 |
|
|
2018
Q4 | $766K | Hold |
6,166
| – | – | 0.26% | 109 |
|
|
2018
Q3 | $977K | Buy |
6,166
+365
| +6% | +$57.8K | 0.29% | 102 |
|
|
2018
Q2 | $812K | Buy |
+5,801
| New | +$812K | 0.25% | 103 |
|